XML 33 R22.htm IDEA: XBRL DOCUMENT v3.20.2
Stockholders' Equity - Additional Information (Detail)
3 Months Ended 9 Months Ended 15 Months Ended
Jul. 06, 2020
USD ($)
$ / shares
shares
Oct. 10, 2019
USD ($)
$ / shares
shares
May 23, 2019
USD ($)
$ / shares
shares
Jul. 30, 2018
USD ($)
$ / shares
shares
Mar. 07, 2018
USD ($)
$ / shares
Sep. 26, 2020
USD ($)
$ / shares
Plan
shares
Dec. 31, 2019
USD ($)
shares
Sep. 28, 2019
USD ($)
$ / shares
shares
Sep. 26, 2020
USD ($)
$ / shares
Plan
shares
Sep. 28, 2019
USD ($)
$ / shares
shares
Sep. 28, 2020
USD ($)
$ / shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Number of equity award option plans | Plan           2     2    
Impact on net loss           $ 22,000   $ 23,000 $ 65,000 $ 70,000  
Gross proceeds from common stock   $ 3,000,000 $ 1,700,000 $ 9,000,000 $ 2,000,000            
Net proceeds from common stock   $ 2,400,000 $ 1,400,000 $ 7,980,000 $ 1,700,000         $ 1,421,000  
Warrants Exercise                 $ 2,479,000    
Common stock issued | shares 400,000                    
Preferred equity interest, value $ 1,600,000                    
Purchase price | $ / shares $ 4.00                    
Securities Purchase Program [Member]                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Common stock issued | shares 400,000                    
Preferred equity interest, value $ 1,600,000                    
Purchase price | $ / shares $ 4.00                    
Stock Options [Member] | Stock Option Plan [Member]                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Number of Shares, Exercised | shares           0   0 0 0  
Impact on net loss           $ 22,000     $ 63,000 $ 62,000 $ 20,000
Impact on basic and diluted net loss per share | $ / shares           $ 0.01     $ 0.03 $ 0.14 $ 0.04
Total compensation cost related to nonvested awards not yet recognized           $ 17,000     $ 17,000    
Weighted-average period                 3 months    
Weighted-average contractual term of options outstanding                 7 years 8 months 12 days    
Weighted-average contractual term of stock options currently exercisable                 7 years 4 months 24 days    
Exercisable options with an exercise price less than the current market value | shares           0     0    
Outstanding options expiration date                 Oct. 31, 2028    
Aggregate exercise price of options                 $ 2,000,000    
Minimum exercise price of options | $ / shares                 $ 19.20    
Maximum exercise price of options | $ / shares                 $ 28,440    
Restricted Stock [Member] | Stock Option Plan [Member]                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Impact on net loss           $ 0   $ 3,000 $ 2,000 $ 8,000  
Impact on basic and diluted net loss per share | $ / shares           $ 0.00   $ 0.01 $ 0.00 $ 0.02  
Total compensation cost related to nonvested awards not yet recognized           $ 0     $ 0    
Stock compensation cost capitalized                 $ 0    
Restricted Stock [Member] | Minimum [Member] | Stock Option Plan [Member]                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Shares of restricted stock under awards all have service conditions and vest over                 1 year    
Restricted Stock [Member] | Maximum [Member] | Stock Option Plan [Member]                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Shares of restricted stock under awards all have service conditions and vest over                 3 years    
(11) Warrants Related to October 2019 financing [Member]                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Warrants outstanding | shares   1,183,400       217,200     217,200    
Warrants, exercisable period   5 years                  
Exercise price of warrants | $ / shares   $ 2.50       $ 2.50     $ 2.50    
Common Shares, Expiration Date                 Oct. 10, 2024    
Number of Warrants Exercised | shares           828 39,528   978,594    
(12) Warrants Related to October 2019 financing [Member]                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Warrants outstanding | shares   82,838       30,916     30,916    
Exercise price of warrants | $ / shares   $ 3.125       $ 3.13     $ 3.13    
Common Shares, Expiration Date   Oct. 08, 2024             Oct. 08, 2024    
(9) Warrants related to July 2018 financing [Member]                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Warrants outstanding | shares       15,428   15,428     15,428    
Warrants, exercisable period       5 years 5 years 7 months 6 days            
Exercise price of warrants | $ / shares       $ 43.75 $ 114.00 $ 43.75     $ 43.75    
Common Shares, Expiration Date                 Jul. 25, 2023    
(10) Warrants related to May 2019 financing [Member]                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Warrants outstanding | shares     170,000     11,900     11,900    
Exercise price of warrants | $ / shares     $ 12.50     $ 12.50     $ 12.50    
Common Shares, Expiration Date     May 23, 2024           May 23, 2024    
(8) Warrants related to July 2018 financing [Member]                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Warrants outstanding | shares       257,142   257,143     257,143    
Exercise price of warrants | $ / shares       $ 35.00   $ 35.00     $ 35.00    
Common Shares, Expiration Date       Jul. 25, 2023         Jul. 25, 2023    
Common Stock [Member]                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Number of shares issued | shares   1,183,400 11,900 257,142           170,000  
Issuance price per share | $ / shares   $ 2.50 $ 10.00 $ 35.00              
Warrant [Member]                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Warrants Exercise           $ 2,000,000,000 $ 99,000   $ 2,500,000